[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344563-105":59,"doc-detail-344563-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","global-incidence-of-lip-oral-cavity-and-pharyngeal-cancers-by-subsite-in-2022","Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022","","Cancers of the lip, oral cavity, and pharynx (LOCP) represent a major worldwide public health challenge. Incidence distributions of new LOCP cases were estimated for 185 countries in 2022 using GLOBOCAN national estimates, Cancer Incidence in Five Continents registry data, and United Nations population statistics, with age-standardized incidence rates. For countries without registry data, subsite-specific estimates were imputed from high-quality regional averages. Worldwide, 758,000 people were diagnosed in 2022, with oral cavity cancer as the largest share, followed by oropharynx, nasopharynx, hypopharynx, salivary gland, and lip cancers. Patterns are interpreted in relation to etiology and cancer control prospects.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/global-incidence-of-lip-oral-cavity-and-pharyngeal-cancers-by-subsite-in-2022/344563/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/global-incidence-of-lip-oral-cavity-and-pharyngeal-cancers-by-subsite-in-2022/344563.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How were LOCP cancer incidence estimates for 2022 generated across countries?","Question",{"text":113,"@type":114},"The analysis used GLOBOCAN national incidence estimates, detailed registry data from Cancer Incidence in Five Continents, and UN population statistics. Age-standardized incidence rates were calculated, and missing registry countries were imputed using regional averages from high-quality registries.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What were the main LOCP cancer subsite shares worldwide in 2022?",{"text":118,"@type":114},"In 2022, 758,000 people were diagnosed worldwide. Oral cavity cancer accounted for about 42% of cases, followed by oropharynx (19.3%), nasopharynx (15.9%), hypopharynx (11.4%), salivary gland (7.3%), and lip (4.2%).",{"name":120,"@type":111,"acceptedAnswer":121},"How do etiologic factors differ across LOCP subsites?",{"text":122,"@type":114},"Oral cavity cancers are often linked to tobacco, alcohol, and areca nut. Oropharyngeal cancers are associated with high-risk HPV (notably HPV16 and HPV18), and nasopharyngeal cancers are linked to EBV infection. Lip cancers are associated with ultraviolet radiation and tobacco, with subtype-specific patterns.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},344563,1790129530,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","DOI: 10. 3322/caac.70048  \nARTICLE  \nGlobal incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022  \nHarriet Rumgay PhD 1  | Murielle Colombet MSc1 |  \nAmanda Ramos da Cunha DDS, MSc, PhD1,2  | Adalberto M. Filho PhD 1  | Saman Warnakulasuriya DSc3,4  | David I. Conway BDS, MPH, PhD5  |  \nAnil Chaturvedi PhD6  | Shama Virani PhD7  | Beatrice Lauby-Secretan PhD8  | Andre L. Carvalho MD, PhD, MPH9 | Suzanne T. Nethan MDS, MPH8  |  \nAhmedin Jemal DVM, PhD10 | Freddie Bray BSc, MSc, PhD1   \n1Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France 2Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil  \n3King’s College London, London, UK  \n4World Health Organization Collaborating Centre for Oral Cancer, London, UK 5School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, UK 6Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA  \n7Genetic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France 8Evidence Synthesis and Classification Branch, International Agency for Research on Cancer, Lyon, France  \n9Early Detection, Prevention, and Infections Branch, International Agency for Research on Cancer, Lyon, France  \n10Surveillance, Prevention, and Health Services Research, American Cancer Society, Atlanta, Georgia, USA  \nCorrespondence  \nHarriet Rumgay, Cancer Surveillance Branch, International Agency for Research on Cancer/ World Health Organization (IARC/WHO), 25 Avenue Tony Garnier, CS 90627, 69366 Lyon Cedex 07, France.  \nEmail: [rumgayh@iarc.who.int](rumgayh@iarc.who.int)  \nABSTRACT  \nCancers of the lip, oral cavity, and pharynx (LOCP) represent a substantial public health challenge worldwide. Using GLOBOCAN national estimates of incidence, detailed cancer registry data from Cancer Incidence in Five Continents, and population statistics from the United Nations, the authors report the distribution of new cases of LOCP cancers in 185 countries by sex in 2022. Age-standardized incidence rates were calculated. For countries lacking registry data, regional averages from highquality registries were used to impute subsite-specific estimates. Worldwide, 758,000 people were diagnosed with LOCP cancers in 2022, with oral cavity cancer accounting for approximately 42% of cases, followed by oropharynx (19.3%), nasopharynx (15. 9%), hypopharynx (11.4%), salivary gland (7.3%), and lip (4.2%) cancers. Oral cavity cancer was the most frequent LOCP subsite among women in 141 countries and among men in 93 countries, and incidence rates were highest in countries in South-Central Asia. Oropharyngeal cancer was the most frequent LOCP subsite among men in 44 countries and among women in five countries across Europe, Northern America, South America, Australia, and New Zealand. Nasopharyngeal cancer was the most common subsite among men in 39 countries and women in 23 countries, mainly in Northern Africa, Middle Africa, and Eastern and South-Eastern Asia. Rates of hypopharyngeal and salivary gland cancers were low globally, although the incidence burden was greater than that of lip cancer. The authors discuss incidence patterns in relation to disease etiology and the prospects of delivering effective cancer control measures, spanning primary prevention, early detection, cancer treatment, and survivorship.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2025 International Agency for Research on Cancer; licensed by American Cancer Society. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC Ltd on behalf of American Cancer Society. This article has been contributed to by U.S. Government employees and their work is in the public dom","cbCaijRiUmcSme1D","https://ap.wps.com/l/cbCaijRiUmcSme1D","pdf",2733033,"English","# Abstract\n# Introduction\n## Disease burden and global estimates\n## Anatomical subsites and etiologic drivers","[{\"question\":\"How were LOCP cancer incidence estimates for 2022 generated across countries?\",\"answer\":\"The analysis used GLOBOCAN national incidence estimates, detailed registry data from Cancer Incidence in Five Continents, and UN population statistics. Age-standardized incidence rates were calculated, and missing registry countries were imputed using regional averages from high-quality registries.\"},{\"question\":\"What were the main LOCP cancer subsite shares worldwide in 2022?\",\"answer\":\"In 2022, 758,000 people were diagnosed worldwide. Oral cavity cancer accounted for about 42% of cases, followed by oropharynx (19.3%), nasopharynx (15.9%), hypopharynx (11.4%), salivary gland (7.3%), and lip (4.2%).\"},{\"question\":\"How do etiologic factors differ across LOCP subsites?\",\"answer\":\"Oral cavity cancers are often linked to tobacco, alcohol, and areca nut. Oropharyngeal cancers are associated with high-risk HPV (notably HPV16 and HPV18), and nasopharyngeal cancers are linked to EBV infection. Lip cancers are associated with ultraviolet radiation and tobacco, with subtype-specific patterns.\"}]","Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 | PDF",1790054438,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a49761db95434e4dd54fc8a6383446bd.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75b5d8fcb4d92a4ac05abc7365af78d8.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e018d064d723276c0825673822fd9296.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/279f19bb6b1dcf0d14a0728a68d38dc4.webp",980,1287]